Business Context and Reporting Period
Company: Alphatec Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 4, 2009
Event: Entry into a Material Definitive Agreement and Unregistered Sales of Equity Securities.
Key Financial Metrics
This filing reports a specific capital raise event rather than periodic operating results. Key transaction metrics include:
- Shares Issued: 3,937,007 shares of common stock.
- Purchase Price: $2.54 per share.
- Aggregate Purchase Price: Approximately $10 million.
- Net Proceeds Received: Approximately $9,900,000.
- Use of Proceeds: General working capital purposes.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics outside of the transaction proceeds.
Material Changes
The primary material change is the increase in equity capital through a private placement with an existing shareholder, HealthpointCapital Partners II, L.P. The transaction was approved by disinterested members of the Board of Directors following independent legal and financial advice.
Guidance, Outlook, and Risks
- Registration Obligation: The Company agreed to use commercially reasonable efforts to file a registration statement on Form S-3 to cover the resale of the shares issued to the Subscriber.
- Regulatory Basis: The sale was conducted in reliance on exemptions from registration under Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D, offered solely to "accredited investors."
- Outlook: Proceeds are designated for general working capital, implying support for ongoing operations without specific project-level guidance provided in this document.
Investor Verification Checklist
- Verify the final net proceeds after all transaction costs are accounted for in the subsequent Form 10-Q.
- Confirm the filing status and effectiveness of the Form S-3 registration statement for the resale of shares.
- Review the full text of the Subscription Agreement (Exhibit to the upcoming 10-Q) for any covenants or restrictions not detailed in this summary.
- Assess the impact of the new share issuance on existing shareholder dilution.